Article
Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease.
Molecular genetics and metabolism - 1 Nov 2011
Torralba-Cabeza Miguel-Ángel, Olivera Susana, Hughes Derralynn A, Pastores Gregory M, Mateo Ramón Nuviala, Pérez-Calvo Juan-Ignacio
Abstract excerpt
Fabry disease (FD) is a lysosomal storage disorder caused by mutations in the α-galactosidase A gene. It is characterized by the deposition of the incompletely metabolized substrate globotriaosylceramide in several cell types and multisystem involvement. Major morbidity results from renal, cardiac and cerebrovascular pathology, mediated by endothelial dysfunction. We examined the potential utility of Cystatin C...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
